生命科学资讯

Novo Nordisk’s amycretin cuts body weight, blood sugar in Phase 2 diabetes trial

Collaborative rule learning promotes interbrain information alignment

Episodic memory involves transient and sparse connectivity aligned to both internal and external events

The novel GlcNAc 6-phosphate dehydratase NagS governs a metabolic checkpoint that controls nutrient signaling in Streptomyces

Context-dependent activation of V1 parvalbumin interneurons enhances visual discrimination

A novel targeting domain directs essential components of the cytosolic iron–sulfur cluster assembly pathway to the mitochondrion of Toxoplasma parasites

Morgan Stanley Upgrades Lonza Group to Overweight, Lifts PT - MarketScreener

How Will Analyst Reactions to ILMN’s Wolfe Conference Pitch Shape Confidence in Its Turnaround Plan? - simplywall.st

Agilent Technologies, Inc. (NYSE:A) Q4 2025 Earnings Call Transcript - MSN

A Look At The Fair Value Of Agilent Technologies, Inc. (NYSE:A) - Yahoo Finance

4 takeaways from pharma’s manufacturing boom

Morgan Stanley upgrades Lonza, citing valuation support ahead of 2026 guide - Investing.com

Agilent Technologies disappoints with new earnings forecast - medwatch.com

Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com Nigeria

Novartis was the sole bidder in $12B deal to buy Avidity

Switzerland: Microsize and Schedio Group to acquire Lonza’s Micro-Macinazione site in Switzerland - Investors in Healthcare

Agilent Technologies (A) Exceeds Q4 Revenue Expectations with St - GuruFocus

Thermo Fisher Scientific prices €2.1B euro-denominated senior notes offering - MSN

The Zacks Analyst Blog Highlights Alphabet, Roche, RTX, Crawford United and C&F Financial - Nasdaq

Thermo Fisher Inaugurates Customer Experience and Bioprocess Centre’s in Hyderabad - Chemical Industry Digest